$CNS
COHEN & STEERS, INC.

2020 Q1 Form 10-Q Financial Statement

#000128481220000123 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $105.8M $94.23M
YoY Change 12.32% -0.25%
Cost Of Revenue $14.10M $12.50M
YoY Change 12.8% -2.34%
Gross Profit $91.70M $81.70M
YoY Change 12.24% 0.12%
Gross Profit Margin 86.65% 86.71%
Selling, General & Admin $62.20M $45.20M
YoY Change 37.61% 4.39%
% of Gross Profit 67.83% 55.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.200M $1.100M
YoY Change 9.09% 0.0%
% of Gross Profit 1.31% 1.35%
Operating Expenses $77.46M $58.79M
YoY Change 31.76% 2.7%
Operating Profit $28.37M $35.44M
YoY Change -19.94% -4.79%
Interest Expense -$20.90M $15.40M
YoY Change -235.71% -670.37%
% of Operating Profit -73.67% 43.46%
Other Income/Expense, Net -$19.84M $14.91M
YoY Change -233.09% -7592.46%
Pretax Income $8.526M $50.35M
YoY Change -83.06% 35.99%
Income Tax $458.0K $10.37M
% Of Pretax Income 5.37% 20.59%
Net Earnings $20.57M $32.54M
YoY Change -36.79% 17.97%
Net Earnings / Revenue 19.44% 34.54%
Basic Earnings Per Share $0.43 $0.69
Diluted Earnings Per Share $0.42 $0.68
COMMON SHARES
Basic Shares Outstanding 47.65M shares 47.15M shares
Diluted Shares Outstanding 48.59M shares 47.64M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.00M $56.40M
YoY Change -23.76% -66.55%
Cash & Equivalents $42.96M $56.39M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $63.70M $60.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $106.7M $116.4M
YoY Change -8.33% -49.74%
LONG-TERM ASSETS
Property, Plant & Equipment $12.09M $14.01M
YoY Change -13.7% -6.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $407.0K $23.00K
YoY Change 1669.57% -99.97%
Other Assets $6.800M $7.100M
YoY Change -4.23% 294.44%
Total Long-Term Assets $227.0M $289.4M
YoY Change -21.58% 46.65%
TOTAL ASSETS
Total Short-Term Assets $106.7M $116.4M
Total Long-Term Assets $227.0M $289.4M
Total Assets $333.7M $405.8M
YoY Change -17.78% -5.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $1.000M
YoY Change -90.0% -85.92%
Accrued Expenses $53.40M $62.90M
YoY Change -15.1% 516.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $82.70M $98.10M
YoY Change -15.7% 108.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.90M $8.100M
YoY Change 71.6% -50.61%
Total Long-Term Liabilities $13.90M $8.100M
YoY Change 71.6% -50.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $82.70M $98.10M
Total Long-Term Liabilities $13.90M $8.100M
Total Liabilities $96.55M $106.3M
YoY Change -9.17% 67.41%
SHAREHOLDERS EQUITY
Retained Earnings -$240.9M -$193.5M
YoY Change 24.5% 54.46%
Common Stock $535.0K $525.0K
YoY Change 1.9% 1.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.7M $174.8M
YoY Change 14.82% 6.36%
Treasury Stock Shares 5.673M shares 5.329M shares
Shareholders Equity $195.5M $235.2M
YoY Change
Total Liabilities & Shareholders Equity $333.7M $405.8M
YoY Change -17.78% -5.39%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $20.57M $32.54M
YoY Change -36.79% 17.97%
Depreciation, Depletion And Amortization $1.200M $1.100M
YoY Change 9.09% 0.0%
Cash From Operating Activities -$5.553M -$29.50M
YoY Change -81.18% 1.48%
INVESTING ACTIVITIES
Capital Expenditures $843.0K $989.0K
YoY Change -14.76% 9.16%
Acquisitions
YoY Change
Other Investing Activities -$7.200M $9.700M
YoY Change -174.23% -638.89%
Cash From Investing Activities -$8.012M $8.739M
YoY Change -191.68% -418.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.59M $10.08M
YoY Change 153.87% -2.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$43.55M -$16.16M
YoY Change 169.45% -339.79%
NET CHANGE
Cash From Operating Activities -$5.553M -$29.50M
Cash From Investing Activities -$8.012M $8.739M
Cash From Financing Activities -$43.55M -$16.16M
Net Change In Cash -$57.11M -$36.93M
YoY Change 54.67% 47.26%
FREE CASH FLOW
Cash From Operating Activities -$5.553M -$29.50M
Capital Expenditures $843.0K $989.0K
Free Cash Flow -$6.396M -$30.49M
YoY Change -79.02% 1.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001284812
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-32236
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
COHEN & STEERS, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1904657
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
280 Park Avenue
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2020Q1 dei City Area Code
CityAreaCode
212
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
832-3232
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
CNS
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47767225 shares
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42960000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101352000 USD
CY2020Q1 us-gaap Investments
Investments
141697000 USD
CY2019Q4 us-gaap Investments
Investments
155213000 USD
CY2020Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
63659000 USD
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
59101000 USD
CY2020Q1 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
145000 USD
CY2019Q4 us-gaap Due From Correspondent Brokers
DueFromCorrespondentBrokers
1743000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12091000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12486000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35961000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38440000 USD
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
19326000 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
19560000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6836000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7091000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
10980000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
7433000 USD
CY2020Q1 us-gaap Assets
Assets
333655000 USD
CY2019Q4 us-gaap Assets
Assets
402419000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12796000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48105000 USD
CY2020Q1 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
6029000 USD
CY2019Q4 cns Distribution And Service Fees Payable
DistributionAndServiceFeesPayable
7318000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40587000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43349000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
23162000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
22194000 USD
CY2020Q1 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
82000 USD
CY2019Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
366000 USD
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
13894000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
13972000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
96550000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
135304000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
41601000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Fair Value
RedeemableNoncontrollingInterestEquityCommonFairValue
53412000 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
333655000 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53436455 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52580246 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
535000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
527000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
644397000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
636788000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-240930000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242461000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7826000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6326000 USD
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5673028 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5329820 shares
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
200672000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
174825000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
195504000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
213703000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
402419000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94226000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
38617000 USD
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
33715000 USD
CY2020Q1 us-gaap Sponsor Fees
SponsorFees
14104000 USD
CY2019Q1 us-gaap Sponsor Fees
SponsorFees
12536000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23588000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11438000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1152000 USD
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1102000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
77461000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
58791000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
28369000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35435000 USD
CY2020Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1149000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-495000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19843000 USD
CY2019Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1541000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2019Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
13864000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1035000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14910000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8526000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
50345000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
458000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10368000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
39977000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7434000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
32543000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47651000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47146000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48591000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47642000 shares
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
39977000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7434000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
32543000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1500000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
398000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19072000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32941000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
213703000 USD
CY2020Q1 us-gaap Dividends
Dividends
19041000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
305000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
25847000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
553000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6775000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
16000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1500000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
195504000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
222646000 USD
CY2019Q1 us-gaap Dividends
Dividends
17662000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
322000 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10353000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6970000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6668000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
797000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6470000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
32543000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
398000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
235161000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
39977000 USD
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
443000 USD
CY2019Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
236000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1152000 USD
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1102000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2479000 USD
CY2019Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2511000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
84000 USD
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
59000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2019Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
13864000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
281000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
58000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-158000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
177000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4716000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9415000 USD
CY2020Q1 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-1598000 USD
CY2019Q1 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
1225000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
440000 USD
CY2019Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
299000 USD
CY2020Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
2011000 USD
CY2019Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
18543000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2343000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3297000 USD
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-35309000 USD
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-32366000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1289000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1633000 USD
CY2020Q1 cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2762000 USD
CY2019Q1 cns Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2720000 USD
CY2020Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-284000 USD
CY2019Q1 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
317000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
968000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8680000 USD
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-459000 USD
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-5454000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5553000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29503000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9634000 USD
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24692000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2392000 USD
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
34420000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
843000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
989000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
73000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8012000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8739000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
259000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
274000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25847000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10353000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18653000 USD
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17015000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
1946000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
2985000 USD
CY2020Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
2639000 USD
CY2019Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
13917000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43548000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16162000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57113000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36926000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1279000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
579000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101352000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92733000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42960000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56386000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1784000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1641000 USD
CY2020Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
388000 USD
CY2019Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
647000 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:22.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Accounting Estimates</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates. The extent to which the COVID-19 pandemic impacts the Company's business, results of operations, financial condition, liquidity or prospects will depend on future developments which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic and the actions taken to contain or address its impact.</span></div><div style="text-indent:22.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Reclassifications—</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company reclassified certain prior period amounts in the condensed consolidated financial statements to conform with the current period presentation. Prior period revenue amounts related to model-based portfolios were reclassified from other (previously reported as portfolio consulting and other) to investment advisory and administration fees.</span></div>
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94226000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
105830000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
94226000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
77346000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
644000 USD
CY2020Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
50300000 USD
CY2019Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
50000000.0 USD
CY2020Q1 cns Number Of New Funds Seeded
NumberOfNewFundsSeeded
1 new_funds_seeded
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
89872000 USD
CY2020Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
14053000 USD
CY2019Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
14980000 USD
CY2020Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
49891000 USD
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
49807000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
407000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
554000 USD
CY2020Q1 us-gaap Investments
Investments
141697000 USD
CY2019Q4 us-gaap Investments
Investments
155213000 USD
CY2020Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
-1230000 USD
CY2019Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
-767000 USD
CY2020Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-20797000 USD
CY2019Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
14631000 USD
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-22027000 USD
CY2019Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
13864000 USD
CY2020Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
12575000 USD
CY2020Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
29050000 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
811000 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
1920000 USD
CY2019Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
14394000 USD
CY2019Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
24319000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
556000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47651000 shares
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
137000 USD
CY2019Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
347000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
8068000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
39977000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12504000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7434000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
20572000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
32543000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47146000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
940000 shares
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
496000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48591000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47642000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210

Files In Submission

Name View Source Status
0001284812-20-000123-index-headers.html Edgar Link pending
0001284812-20-000123-index.html Edgar Link pending
0001284812-20-000123.txt Edgar Link pending
0001284812-20-000123-xbrl.zip Edgar Link pending
cns-20200331.htm Edgar Link pending
cns-20200331.xsd Edgar Link pending
cns-20200331_cal.xml Edgar Link unprocessable
cns-20200331_def.xml Edgar Link unprocessable
cns-20200331_g1.jpg Edgar Link pending
cns-20200331_htm.xml Edgar Link completed
cns-20200331_lab.xml Edgar Link unprocessable
cns-20200331_pre.xml Edgar Link unprocessable
cns10q-33120ex311.htm Edgar Link pending
cns10q-33120ex312.htm Edgar Link pending
cns10q-33120ex321.htm Edgar Link pending
cns10q-33120ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending